Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Request
Blocked Timeslot
Restricted Timeslot
Search Exhibitors/Products
|
AbbVie |
MGH-3-CORTEZHILL A |
|
|
|
|  |  |  |
|
AbbVie |
MGH-3-CORTEZHILL B |
|
|
|
| | | |
|
AbbVie |
MGH-3-CORTEZHILL C |
|
|
|
| | | |
|
AbbVie |
MGH-3-HILLCREST A |
|
|
|
| | | |
|
AbbVie |
MGH-3-HILLCREST B |
|
|
|
| | | |
|
AbbVie |
MGH-3-HILLCREST C |
|
|
|
| | | |
|
AbbVie |
MGH-3-HILLCREST D |
|
|
|
| | | |
|
AbbVie |
MGH-3-TORREYHILLS A |
|
|
|
| | | |
|
AbbVie |
MGH-3-BANKERS HILL |
|
|
|
| | | |
|
AbbVie |
2105 |
|
|
|
| | | |
|
Acrotech Biopharma |
2301 |
|
|
|
| | | |
|
ADC Therapeutics |
MGH-2-GASLAMP A |
|
|
|
| | | |
|
ADC Therapeutics |
MM-1-OCEANSIDE |
|
|
|
| | | |
|
ADC Therapeutics |
1227 |
|
|
|
| | | |
|
Agios Pharmaceuticals |
105 |
|
|
|
| | | |
|
American Society of Hematology |
1215 |
|
|
|
| | | |
|
Apellis Pharmaceuticals |
513 |
|
|
|
| | | |
|
Apellis Pharmaceuticals |
612 |
|
|
|
| | | |
|
argenx |
2705 |
|
|
|
| | | |
|
Ascentage Pharma |
3337 |
|
|
|
| | | |
|
Astellas Pharma US, Inc. |
2421 |
|
|
|
| | | |
|
AstraZeneca |
COBALT520 |
|
|
|
| | | |
|
AstraZeneca |
COBALT501C |
|
|
|
| | | |
|
AstraZeneca |
COBALT501B |
|
|
|
| | | |
|
AstraZeneca |
COBALT501A |
|
|
|
| | | |
|
AstraZeneca |
COBALT500 |
|
|
|
| | | |
|
AstraZeneca |
COBALT502A |
|
|
|
| | | |
|
AstraZeneca |
COBALT502B |
|
|
|
| | | |
|
AstraZeneca |
EMB4 |
|
|
|
| | | |
|
AstraZeneca |
EMB5 |
|
|
|
| | | |
|
AstraZeneca |
EMB6 |
|
|
|
| | | |
|
AstraZeneca |
EMB19 |
|
|
|
| | | |
|
AstraZeneca |
EMB20 |
|
|
|
| | | |
|
AstraZeneca |
EMB21 |
|
|
|
| | | |
|
AstraZeneca |
EMB22 |
|
|
|
| | | |
|
AstraZeneca |
1433 |
|
|
|
| | | |
|
Bayer |
848 |
|
|
|
| | | |
|
Beam Therapeutics |
MGH-2-BALBOA C |
|
|
|
| | | |
|
Beam Therapeutics |
1449 |
|
|
|
| | | |
|
BioMarin Pharmaceutical Inc. |
1225 |
|
|
|
| | | |
|
Blueprint Medicines |
541 |
|
|
|
| | | |
|
BMS |
OMNI-Gallery 2 |
|
|
|
| | | |
|
BMS |
OMNI-Gallery 3A |
|
|
|
| | | |
|
BMS |
OMNI-Gallery 3B |
|
|
|
| | | |
|
BMS |
OMNI-4-GASLAMP1 |
|
|
|
| | | |
|
BMS |
OMNI-4-GASLAMP2 |
|
|
|
| | | |
|
BMS |
OMNI-4-GASLAMP3 |
|
|
|
| | | |
|
BMS |
OMNI-4-GASLAMP4 |
|
|
|
| | | |
|
BMS |
OMNI-4-GASLAMP5 |
|
|
|
| | | |
|
Bristol Myers Squibb |
2609 |
|
|
|
| | | |
|
Caribou Biosciences, Inc. |
3253 |
|
|
|
| | | |
|
Citius Pharmaceuticals |
3343 |
|
|
|
| | | |
|
Cogent Biosciences |
2804 |
|
|
|
| | | |
|
Conexiant |
2100 |
|
|
|
| | | |
|
CSL Behring |
625 |
|
|
|
| | | |
|
Daiichi Sankyo |
HB11 |
|
|
|
| | | |
|
Daiichi Sankyo |
HB10 |
|
|
|
| | | |
|
Daiichi Sankyo |
133 |
|
|
|
| | | |
|
Eli Lilly and Company |
OMNI-5-BALBOA 2 |
|
|
|
| | | |
|
Eli Lilly and Company |
OMNI-5-BALBOA 1 |
|
|
|
| | | |
|
Eli Lilly and Company |
1715 |
|
|
|
| | | |
|
Enable Injections |
2348 |
|
|
|
| | | |
|
Gamida Cell |
2247 |
|
|
|
| | | |
|
Gamida Cell |
2346 |
|
|
|
| | | |
|
Genentech |
HB6 |
|
|
|
| | | |
|
Genentech |
715 |
|
|
|
| | | |
|
Gilead and Kite Oncology |
MM-1-LEUCADIA |
|
|
|
| | | |
|
Gilead and Kite Oncology |
MM-1-LAGUNA |
|
|
|
| | | |
|
Gilead and Kite Oncology |
EMB40 |
|
|
|
| | | |
|
Gilead and Kite Oncology |
EMB41 |
|
|
|
| | | |
|
Gilead and Kite Oncology |
EMB58 |
|
|
|
| | | |
|
Gilead and Kite Oncology |
EMB59 |
|
|
|
| | | |
|
Gilead and Kite Oncology |
1233 |
|
|
|
| | | |
|
GSK |
Presidio 2 |
|
|
|
| | | |
|
GSK |
Presidio 1 |
|
|
|
| | | |
|
GSK |
EMB11 |
|
|
|
| | | |
|
GSK |
EMB12 |
|
|
|
| | | |
|
GSK |
EMB13 |
|
|
|
| | | |
|
GSK |
EMB14 |
|
|
|
| | | |
|
GSK |
1015 |
|
|
|
| | | |
|
Ichnos Sciences |
2940 |
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
EMB77 |
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
EMB78 |
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
1453 |
|
|
|
| | | |
|
Jazz Pharmaceuticals |
EMB48 |
|
|
|
| | | |
|
Jazz Pharmaceuticals |
EMB51 |
|
|
|
| | | |
|
Jazz Pharmaceuticals |
2819 |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-CARDIFF/CARLSBAD |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-ENCINITAS |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-DELMAR |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-PALOMAR |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-MIRAMAR |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-MISSION HILLS |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-DANA POINT |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-LA COSTA |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-NEWPORT |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-CATALINA |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-LA JOLLA |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-CORONADO |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-MALIBU |
|
|
|
| | | |
|
Johnson & Johnson |
EMB7 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB8 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB9 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB10 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB15 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB16 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB17 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB18 |
|
|
|
| | | |
|
Johnson & Johnson -Advocacy |
EMB39 |
|
|
|
| | | |
|
Johnson & Johnson -Advocacy |
EMB60 |
|
|
|
| | | |
|
Johnson & Johnson Innovative Medicine |
2129 |
|
|
|
| | | |
|
Karyopharm Therapeutics Inc. |
733 |
|
|
|
| | | |
|
Kura Oncology |
2701 |
|
|
|
| | | |
|
Mallinckrodt Pharmaceuticals |
3441 |
|
|
|
| | | |
|
Melinta Therapeutics |
1857 |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-GASLAMP B |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-GASLAMP C |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-GASLAMP D |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-LAJOLLA A |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-LAJOLLA B |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-OLDTOWN A |
|
|
|
| | | |
|
Merck & Co., Inc |
MGH-2-OLDTOWN B |
|
|
|
| | | |
|
Merck & Co., Inc |
432 |
|
|
|
| | | |
|
Miltenyi Biotec |
553 |
|
|
|
| | | |
|
Notable Labs |
2554 |
|
|
|
| | | |
|
Novartis |
Torrey Pines 2 |
|
|
|
| | | |
|
Novartis |
Torrey Pines 3 |
|
|
|
| | | |
|
Novartis |
MM-L/2-Torrey Pines 1 |
|
|
|
| | | |
|
Novartis |
EMB23 |
|
|
|
| | | |
|
Novartis |
2529 |
|
|
|
| | | |
|
Novo Nordisk Healthcare AG |
EMB36 |
|
|
|
| | | |
|
Novo Nordisk Healthcare AG |
1748 |
|
|
|
| | | |
|
NURIX |
655 |
|
|
|
| | | |
|
Pfizer |
HB2 |
|
|
|
| | | |
|
Pfizer |
HB1 |
|
|
|
| | | |
|
Pfizer |
EMB1 |
|
|
|
| | | |
|
Pfizer |
EMB2 |
|
|
|
| | | |
|
Pfizer |
EMB3 |
|
|
|
| | | |
|
Pfizer |
EMB24 |
|
|
|
| | | |
|
Pfizer |
833 |
|
|
|
| | | |
|
Protagonist Therapeutics, Inc |
1549 |
|
|
|
| | | |
|
Sanofi |
MM-1-SANTA ROSA |
|
|
|
| | | |
|
Sanofi |
EMB26 |
|
|
|
| | | |
|
Sanofi |
EMB27 |
|
|
|
| | | |
|
Sanofi |
EMB28 |
|
|
|
| | | |
|
Sanofi |
EMB29 |
|
|
|
| | | |
|
Sanofi |
EMB30 |
|
|
|
| | | |
|
Sanofi |
EMB31 |
|
|
|
| | | |
|
Sanofi |
EMB32 |
|
|
|
| | | |
|
Sanofi |
EMB33 |
|
|
|
| | | |
|
Sanofi |
EMB34 |
|
|
|
| | | |
|
Sanofi |
EMB35 |
|
|
|
| | | |
|
Sanofi |
1415 |
|
|
|
| | | |
|
Sobi, Inc. |
2429 |
|
|
|
| | | |
|
Star Therapeutics |
108 |
|
|
|
| | | |
|
Sumitomo Pharma America |
3305 |
|
|
|
| | | |
|
Taiho Oncology - Commercial |
615 |
|
|
|
| | | |
|
Taiho Oncology, Inc. |
305 |
|
|
|
| | | |
|
Takeda |
OMNI-Gallery 1 |
|
|
|
| | | |
|
Takeda |
EMB55 |
|
|
|
| | | |
|
Takeda |
EMB56 |
|
|
|
| | | |
|
Takeda |
EMB57 |
|
|
|
| | | |
|
Takeda |
2829 |
|
|
|
| | | |
|
Takeda Pharmaceuticals |
EMB42 |
|
|
|
| | | |
|
Takeda Pharmaceuticals |
EMB43 |
|
|
|
| | | |
|
Vaniam Group |
1155 |
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
EMB49 |
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
EMB50 |
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
504 |
|
|
|
| | | |
|
Viracta Therapeutics |
3147 |
|
|
|
| | | |
|
Worldwide Clinical Trials |
3105 |
|
|
|
| | | |